about
Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI)In vivo reactivation of DNases in implanted human prostate tumors after administration of a vitamin C/K(3) combination.Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer.Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cellsForced expression of heat-shock protein 70 increases the secretion of Hsp70 and provides protection against tumour growth.γ-Oryzanol reduces caveolin-1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines.Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis.Doxazosin: a new cytotoxic agent for prostate cancer?
P2860
Q24801760-561A6CC5-1B0E-4DF2-AACF-6B640AC70F1EQ31706395-D1CF8691-1F5C-477B-8C04-FD67670ED30BQ35650902-2FA14A9A-63A8-4BE3-AB0E-EC3FE7688376Q36080935-5F2DA400-E1AF-4786-B35D-987AD8631C52Q36627473-C1ECF40E-B1BE-4536-856C-4648D8D12AAFQ38806106-41129ADE-4675-403F-A35A-451F397CBC26Q38916726-5B678013-05BC-49E2-B38B-77F62815DFD3Q43201425-25CE425D-40D0-4D49-A38F-2EC7FEF85CD9Q50512920-3B684B7C-CED6-4DDF-BA3B-9B812BFC227B
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Management of relapsing disease in prostate cancer.
@ast
Management of relapsing disease in prostate cancer.
@en
type
label
Management of relapsing disease in prostate cancer.
@ast
Management of relapsing disease in prostate cancer.
@en
prefLabel
Management of relapsing disease in prostate cancer.
@ast
Management of relapsing disease in prostate cancer.
@en
P1433
P1476
Management of relapsing disease in prostate cancer.
@en
P2093
P304
P356
10.1002/1097-0142(19920701)70:1+<329::AID-CNCR2820701322>3.0.CO;2-Z
P407
P433
P577
1992-07-01T00:00:00Z